Takis research activities and services have been reported in the 29th September Issue of "Il Sole 24ore", the most important Italian Newspaper about Economy and Finance. Here, the Biotechnology sector was described as one of the most promising for investors. Particularly, Takis Research in OncoImmunology were reported to potentially result in significant advances in Cancer Treatment.

Here the article (in Italian):